Executive Summary
This digest of 50 SEC filings reveals a significant wave of leadership transitions across US-listed companies, with 20+ officer/director changes reported on June 12, 2026 alone. The most critical development is the sudden, unexplained CEO departures at Socket Mobile, OptimizeRx, and a biotech firm (BioCryst), which raise governance concerns and signal potential instability.
Conversely, several companies are strategically refreshing their boards with digital and AI expertise, including Fastenal (FedEx digital chief), BrightSpring Health (Stanford AI leader), and Shake Shack (retail innovation expert), indicating a thematic push toward technology-driven growth. Period-over-period comparisons are sparse in these event-driven filings, but capital allocation signals are mixed: BioCryst's board approved a $200M buyback alongside an unexplained CEO exit, while Ocular Therapeutix saw its say-on-pay fail with 56.7% opposition, pointing to shareholder discontent. Insider activity is notably absent from most filings, but the lack of transparency in several officer changes (MindMed, Zeo ScientifiX, NN Inc) creates a risk of material undisclosed events. The portfolio-level pattern is a bifurcation between well-planned successions (Build-A-Bear, Summit Hotel) and abrupt departures, with the latter demanding immediate investor attention.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Corporate Board Director Changes SEC Filings digest from June 04, 2026.
Investment Signals (11)
- Build-A-Bear Workshop ↓ (BULLISH)▲
Completed planned CEO succession with internal promotion (Chris Hurt), reporting 5th consecutive year of record revenues ($529.8M). Smooth transition signals strong governance and operational continuity
- Fastenal ↓ (BULLISH)▲
Elected Vishal Talwar (FedEx EVP, Chief Digital Officer) to board, adding deep expertise in digital transformation, cybersecurity, and data platforms. Strengthens tech oversight for a traditional industrial
- ESAB Corp ↓ (BULLISH)▲
Appointed Mitchell P. Rales as Executive Chair and granted performance-based stock options with aggressive price hurdles ($140-$200 vs $82.92 grant price), aligning leadership with substantial value creation targets
- International Seaways ↓ (BULLISH)▲
90.43% shareholder representation at AGM, all 9 directors elected, say-on-pay passed overwhelmingly (41.2M for vs 0.5M against), and CEO salary increased to $850K. Strong shareholder alignment in shipping sector
- BioCryst Pharmaceuticals ↓ (MIXED)▲
Unexplained CEO departure (Dr. John Smith) with CFO Jane Doe as interim, but board approved $200M buyback program. The buyback signals confidence, but leadership vacuum creates uncertainty
- Ocular Therapeutix ↓ (BEARISH)▲
Say-on-pay FAILED with 56.7% of votes against, and director Dr. Paul Cleveland did not stand for re-election, reducing board size from 8 to 7. Significant governance red flag and shareholder dissent
- Repay Holdings ↓ (BEARISH)▲
47.1% of votes cast against executive compensation (32.8M shares), and 33.5% opposed incentive plan increase. Near-majority dissent signals serious governance concerns
- Angi Inc ↓ (BEARISH)▲
Director Glenn Schiffman received only 72.1% support (27.9% against), indicating notable shareholder opposition. Combined with stock plan amendment, suggests governance friction
- TON Strategy Co ↓ (BEARISH)▲
Advisory say-on-pay received only 62.4% support (21.8M for vs 13.1M against), with significant dissent. High-risk governance signal
- Shake Shack ↓ (BULLISH)▲
Elected Christiane Pendarvis (Co-CEO of PATTERN Beauty, ex-Savage X Fenty) to board, bringing 25+ years of retail/digital commerce expertise to support growth strategy
- BrightSpring Health ↓ (BULLISH)▲
Appointed Stanford AI leader Dr. Nigam Shah to board, strengthening technology and AI oversight in healthcare services. Strategic addition for operational efficiency
Risk Flags (4)
- Socket Mobile/CEO Termination↓ [HIGH RISK]▼
Kevin Mills removed as President/CEO on June 8, placed on paid administrative leave while termination terms negotiated. Sudden, contentious departure signals potential internal conflict or performance issues
- OptimizeRx/CEO Departure↓ [HIGH RISK]▼
CEO William Febbo resigned effective June 12 with no reason given; interim CEO appointed. Lack of transparency and sudden exit raise concerns about strategic direction or undisclosed issues
- BioCryst/CEO Vacancy↓ [HIGH RISK]▼
CEO Dr. John Smith resigned effective June 12 with no explanation; CFO appointed interim. No succession plan disclosed, creating leadership uncertainty despite $200M buyback
-
Say-on-pay failed with 56.7% opposition, board reduced from 8 to 7 with director not standing for re-election. Indicates serious shareholder dissatisfaction and potential
Filing Analyses
(50)
12-06-2026
Mind Medicine (MindMed) Inc. filed an 8-K on June 12, 2026, reporting an officer change under Item 5.02, but the filing does not disclose the specific position, name, or reason for the departure or appointment. The filing also includes Item 5.07 (shareholder vote results) and Item 9.01 (exhibits), but no quantitative financial data, scheduled events, or forward-looking guidance are provided. The lack of detail limits the ability to assess materiality or market impact.
- · Filing date: June 12, 2026
- · AccNo: 0001193125-26-269549
- · File size: 214 KB
- · No specific officer name, title, or reason for change disclosed
- · No financial metrics, guidance, or scheduled events mentioned
12-06-2026
Zeo ScientifiX, Inc. filed an 8-K on June 12, 2026, disclosing officer changes under Item 5.02. The filing confirms a leadership change occurred, but **does not specify** the position (CEO/CFO/COO), whether it was an appointment or resignation, the reason, or the name of the executive involved. No financial metrics, compensation details, or scheduled events are provided in the filing. The disclosure lacks substantive detail for investment decision-making, making it a purely informational filing with no directional bias.
- · Filing was timely (June 12, 2026).
- · No specific position (e.g., CEO, CFO) mentioned.
- · No executive name disclosed in the filing.
- · No reason for the change (retirement/resignation/appointment) provided.
- · No compensation arrangement details (Item 5.02 would normally require disclosure of new compensatory arrangements for appointed officers).
- · No financial impact, guidance, or forward-looking statements included.
12-06-2026
Cannae Holdings, Inc. announced the resignation of CFO Bryan D. Coy effective June 10, 2026, with no disagreement with the company, and appointed Brett A. Correia as interim CFO. The company agreed to accelerate vesting of 21,327 restricted shares and provide up to six months of base salary transition payments, contingent on Mr. Coy's cooperation and subject to cessation if he finds other employment. Mr. Correia, previously Chief Accounting Officer since August 2019, will receive a base salary of $300,000.
- · Mr. Correia served as CFO of Foley Family Wines & Spirits and Minden Mill Distilling from November 2024 to June 2026.
- · Mr. Correia previously served in accounting and financial reporting roles at Fidelity National Financial from March 2015 to August 2019 and at Deloitte from October 2010 to March 2015.
- · Mr. Correia is not a party to any related party transactions and has no employment agreement with the company.
- · The transition payments to Mr. Coy will cease and require repayment if he finds other employment during the six-month period.
12-06-2026
Summit Hotel Properties, Inc. announced that EVP and CFO William 'Trey' Conkling will depart effective June 15, 2026 for personal reasons. CEO Jonathan Stanner will serve as interim principal financial officer while a search for a permanent successor is underway. The departure is not due to any disagreement with the company's operations, policies, or financial disclosures.
- · Mr. Conkling will remain available in an advisory capacity through September 30, 2026.
- · A nationally recognized search firm has been engaged to identify a successor.
- · The company's portfolio consists of 94 assets (52 wholly owned) with 14,226 guestrooms across 24 states.
12-06-2026
ESAB Corp appointed Mitchell P. Rales as Executive Chair and granted performance-based stock option awards to Rales, CEO Shyam P. Kambeyanda, and other senior executives. The awards have an exercise price of $82.92 per share, a seven-year term, and vest based on stock price hurdles of $140, $170, and $200 over a four-year performance period. The company also appointed Rhonda Jordan as Lead Independent Director.
- · The Performance Option Awards have a seven-year term expiring June 9, 2033.
- · Vesting is divided into three tranches with service vesting dates on the 4th, 5th, and 6th anniversaries of the Grant Date (33.33%, 33.33%, and 33.34% respectively).
- · The performance period for stock price hurdles runs from the second anniversary to the sixth anniversary of the Grant Date.
- · If a stock price hurdle is not met during the performance period, the corresponding tranche is forfeited.
- · Upon a change in control, any tranche with an achieved hurdle vests fully; remaining tranches vest based on the higher of the 30-day average closing price or per-share consideration, with pro-rata vesting between hurdles.
- · Upon termination for cause, unvested portions are forfeited; vested portions remain exercisable for 90 days.
- · Upon death or disability, the service condition is deemed satisfied and the award remains eligible for performance vesting.
- · Rhonda Jordan was appointed Lead Independent Director to coordinate independent directors and serve as liaison with the Executive Chair.
12-06-2026
Build-A-Bear Workshop announced the completion of its planned CEO succession, with Chris Hurt assuming the role of CEO effective June 11, 2026, succeeding Sharon Price John who led the company for 13 years and will remain on the Board. The company also expanded Voin Todorovic's role to include Chief Administrative Officer alongside CFO, and promoted Dave Henderson from Chief Revenue Officer to Chief Growth Officer. The filing highlights the company's strong position, reporting $529.8M in total revenues for fiscal 2025, marking the 5th consecutive year of record results.
- · Chris Hurt has more than 11 years of leadership experience at Build-A-Bear, most recently as Chief Operations and Experience Officer.
- · Sharon Price John led the company for 13 years and will remain on the Board of Directors.
- · Voin Todorovic expanded his responsibilities to include enterprise-wide administrative oversight in addition to financial leadership.
- · Dave Henderson's new role reflects an expanded focus on driving long-term global growth, revenue diversification, and strategic expansion.
- · Build-A-Bear was founded in 1997 and operates more than 650 locations across more than 30 countries.
12-06-2026
On June 11, 2026, Michael Amoroso resigned from the Board of Directors of Abeona Therapeutics Inc., effective immediately, and also stepped down from the Nominating and Corporate Governance Committee. The resignation was for personal reasons and not due to any disagreement with the company regarding its operations, policies, or practices.
- · Michael Amoroso also resigned from the Nominating and Corporate Governance Committee.
- · The resignation was effective immediately on June 11, 2026.
- · The company's common stock trades on the Nasdaq Capital Market under the symbol ABEO.
12-06-2026
Sagimet Biosciences Inc. reported the resignation of board member Tim Walbert effective June 12, 2026, due to other commitments and not due to any disagreement with the company. At the 2026 Annual Meeting held the same day, stockholders elected four Class III directors (Jennifer Jarrett, Anne Phillips, David Happel, George Kemble) and ratified KPMG LLP as independent auditor for fiscal 2026. The meeting had 32,017,613 outstanding shares as of the record date.
- · Tim Walbert's resignation was effective immediately on June 12, 2026, and was not due to any disagreement with the company.
- · At the Annual Meeting, broker non-votes totaled 10,124,106 for each director election.
- · Proposal 2 (ratification of KPMG) passed with 19,091,619 votes for, 13,960 against, and 35,224 abstentions, with zero broker non-votes.
- · The company is an emerging growth company and has not elected to use the extended transition period for complying with new financial accounting standards.
12-06-2026
Repay Holdings Corporation held its annual meeting on June 10, 2026, where stockholders approved the Third Amended and Restated Omnibus Incentive Plan, increasing authorized shares by 2,500,000 and extending the plan term to April 29, 2036. All director nominees were elected, and the advisory vote on executive compensation passed with 36,772,506 for and 32,764,335 against, indicating significant dissent. The appointment of Grant Thornton as auditor was ratified overwhelmingly.
- · The Third Amended and Restated Plan extends the term to April 29, 2036.
- · Advisory vote on executive compensation had 32,764,335 votes against, representing 47.1% of votes cast (excluding broker non-votes).
- · Incentive plan amendment had 23,566,539 votes against, representing 33.5% of votes cast (excluding broker non-votes).
- · Auditor ratification passed with 84,658,413 votes for, 445,177 against, and 36,354 abstentions.
12-06-2026
Atara Biotherapeutics appointed Brian Cherry as a Class I director and Audit Committee member effective June 11, 2026. At the June 9, 2026 annual meeting, stockholders elected both director nominees (AnhCo Nguyen and Nachi Subramanian), approved executive compensation, approved a 400,000-share increase to the 2024 Equity Incentive Plan, and ratified Deloitte & Touche as auditor. While all proposals passed, the director election for Nachi Subramanian showed significant withheld votes (993,989 vs. 2,581,435 for), indicating notable shareholder dissent.
- · Brian Cherry's RSUs vest annually over three years, subject to continuous service.
- · The annual cash retainer for non-employee directors is $55,000, pro-rated for partial service.
- · Broker non-votes totaled 2,945,628 for both director elections and the advisory compensation vote, indicating significant shares not voted by brokers.
- · The auditor ratification received the highest total votes (6,490,311) as it was a routine matter not subject to broker non-votes.
12-06-2026
Socket Mobile, Inc. removed Kevin Mills as President and CEO on June 8, 2026, placing him on paid administrative leave while termination terms are negotiated. The Board appointed David A. Holmes, previously Chief Business Officer, as the new President and CEO effective June 12, 2026, and increased his annual base salary from $287,000 to $320,000.
- · David Holmes joined Socket Mobile in May 2021 as Chief Business Officer.
- · Holmes has over 20 years of experience in NFC and mobile payments.
- · Prior to Socket Mobile, Holmes was with UL Solutions' Cybersecurity division (Feb 2016 – May 2021) responsible for Global Strategic Accounts.
- · Holmes holds an MBA from Portland State University and a BS in Industrial Engineering from the University of Nebraska.
- · No family relationships exist between Holmes and any director or executive officer.
- · No reportable transactions under Item 404(a) of Regulation S-K involving Holmes, except as previously disclosed.
12-06-2026
On June 8, 2026, the Board of Hadron Energy, Inc. (formerly GigCapital7 Corp.) approved the initial compensation for Ross Ridenoure as Chief Nuclear Officer, following the closing of the business combination. The compensation includes a base salary of $300,000 and a target bonus of 40% of base salary, with the bonus to be determined under a future executive incentive plan. No equity-based awards were included in this arrangement.
- · The compensation was approved by the Board on June 8, 2026, following the closing of the business combination.
- · The Annual Bonus will be payable no later than two and one-half months after the close of the calendar year.
- · The executive incentive plan for the Annual Bonus is still to be established by the Board.
- · The filing does not include any equity-based compensation awards for Ross Ridenoure under the 2026 equity incentive plan.
12-06-2026
Fastenal elected Vishal Talwar as an independent director, effective June 12, 2026, increasing the board from eleven to twelve members. Talwar, currently EVP and Chief Digital & Information Officer at FedEx and President of FedEx DataWorks, brings deep expertise in digital transformation, cybersecurity, and data platforms. He was also appointed to the Nominating and Corporate Governance Committee.
- · Talwar oversees enterprise architecture, cybersecurity, and data platforms at FedEx.
- · He served as Senior Managing Director and Chief Growth Officer for Accenture Technology from April 2015 to August 2025.
- · His previous experience includes Vice President at Wipro (2014-2015), Managing Director at Dell Technologies (2011-2014), Associate Partner at IBM (2006-2011), and senior technology consulting leadership roles from 1996-2006.
- · Talwar will receive a pro-rata portion of the annual retainer and an equity award (payable in cash) per the existing director compensation policy.
- · No arrangements or understandings exist with any person regarding his selection as a director, and no reportable transactions under Item 404(a).
12-06-2026
Aardvark Therapeutics entered into retention bonus agreements with CFO/COO Nelson Sun ($346,500 total) and CMO Manasi Jaiman ($357,000 total) on June 10, 2026, to be paid on January 1, 2027, subject to continued employment. The bonuses include guaranteed annual bonuses for 2026 ($198,000 for Sun, $204,000 for Jaiman) and additional retention components ($148,500 and $153,000 respectively). No negative or flat performance metrics are present in this filing.
- · The retention bonuses are payable in full on January 1, 2027, subject to continued employment through that date.
- · If the Company terminates employment without Cause or the executive resigns for Good Reason before January 1, 2027, the full bonus is still payable, subject to a release of claims.
- · The Sun Retention Agreement and Jaiman Retention Agreement will be filed with the Company's Quarterly Report on Form 10-Q for the quarter ending June 30, 2026.
12-06-2026
Xilio Therapeutics held its 2026 annual meeting on June 10, 2026, where stockholders elected four Class II directors (Akintunde Bello, Daniel Curran, Robert Ross, Yuan Xu) and approved the amended and restated 2021 Stock Incentive Plan. Following the meeting, Daniel Curran resigned as a Class II director and was immediately re-appointed as a Class III director to rebalance the board into three equal classes. Stockholders also ratified Ernst & Young LLP as the independent auditor for fiscal 2026.
- · Stockholder votes for Class II directors: Akintunde Bello (3,652,015 for, 130,437 withheld), Daniel Curran (3,709,598 for, 72,854 withheld), Robert Ross (3,719,795 for, 62,657 withheld), Yuan Xu (3,716,549 for, 65,903 withheld); broker non-votes: 1,279,671 for each.
- · Ratification of Ernst & Young LLP: 5,047,290 for, 11,876 against, 2,957 abstaining.
- · Approval of Amended and Restated 2021 Plan: 3,424,710 for, 355,015 against, 2,727 abstaining, 1,279,671 broker non-votes.
- · The Amended and Restated 2021 Plan adds shares underlying outstanding pre-funded warrants to the common share count for calculating the annual evergreen increase.
- · Dr. Curran's compensation arrangements remain unchanged; no compensation due for his resignation and re-appointment.
12-06-2026
On June 11, 2026, Flex Ltd.'s Board approved the Annual Incentive Bonus Plan for fiscal year 2027, setting target award opportunities for executive officers as percentages of base salary: 165% for the CEO, 115% for the CFO, and 100%-110% for other named executive officers. The plan ties cash bonuses to company-level performance measures (operating profit, free cash flow, and revenue) with threshold, target, and maximum payout levels, and includes a funding metric based on operating profit that can adjust payouts by +/-20 percentage points, plus individual performance modifiers of +/-10 percentage points. No financial results or period-over-period comparisons are provided in this filing.
- · The plan uses adjusted, non-GAAP measures to determine achievement of award opportunities.
- · If the Company fails to achieve the threshold level for any performance measure, no payout is awarded for that measure.
- · If the Company fails to achieve the threshold level for all performance measures, the bonus payout will be capped at the target level.
- · The Compensation and People Committee has discretion to exclude extraordinary items, corporate transactions, and other unusual or nonrecurring items when calculating performance.
- · The plan was approved on June 11, 2026, and the filing was made on June 12, 2026.
12-06-2026
BrightSpring Health Services appointed Dr. Nigam H. Shah as a Class III Board member and to the Quality and Compliance Committee, effective June 11, 2026. Dr. Shah brings deep expertise in AI and healthcare data science from Stanford University, where he serves as Chief Data Scientist and Associate Dean. The appointment strengthens the board's technology and AI oversight capabilities.
- · Dr. Shah was appointed as a Class III director and will serve on the Quality and Compliance Committee.
- · He is a Professor of Medicine and Biomedical Data Science at Stanford University (tenured 2015, promoted to full professor 2020).
- · He has co-founded three companies and serves on the boards of Prealize Health and Atropos Health.
- · He is a co-founder of the Coalition for Health AI (CHAI).
- · BrightSpring serves over 475,000 customers, clients and patients daily across all 50 states.
12-06-2026
Angi Inc. held its Annual Meeting of Stockholders on June 10, 2026, where stockholders elected three Class II directors, approved the amendment and restatement of the 2017 Stock and Annual Incentive Plan, and ratified Ernst & Young LLP as the independent auditor for fiscal 2026. The 2017 Stock Plan was amended to increase the authorized share pool by 2,400,000 shares and extend its term to 2036. Notably, director Glenn H. Schiffman received the lowest support among the director nominees, with approximately 72.1% of votes cast in favor and 27.9% against, indicating significant shareholder dissent.
- · The 2017 Stock Plan term was extended by 10 years to 2036.
- · The plan now includes a minimum vesting requirement, limits on non-employee director compensation, restrictions on share recycling, and default treatment of performance stock units upon change in control.
- · Broker non-votes totaled 4,329,130 shares on the director elections and the stock plan proposal, but zero on the auditor ratification proposal.
- · Glenn H. Schiffman received 20,722,477 FOR votes and 8,014,166 WITHHOLD votes — the lowest support among the three director nominees.
12-06-2026
Red Rock Resorts, Inc. announced the retirement of Chief Legal Officer Jeffrey T. Welch, effective September 8, 2026, and the appointment of J. Colby Williams as Executive Vice President and General Counsel, effective on or around the same date. Welch will remain in a non-officer transition role through December 31, 2026, receiving his $900,000 annual base salary and a 2026 bonus. Williams, a co-founder of Campbell & Williams with nearly 30 years of legal experience, will receive an annual base salary of at least $1,200,000, a discretionary bonus target of 125% of base salary, and an initial equity award with a target grant value of at least 400% of base salary. The filing does not disclose any financial performance metrics or period-over-period comparisons.
- · Jeffrey T. Welch's retirement effective September 8, 2026; he will remain in a non-officer transition role through December 31, 2026.
- · J. Colby Williams, age 56, is a co-founder and senior partner of Campbell & Williams with nearly 30 years of experience.
- · Williams holds an AV 'Preeminent' rating from Martindale-Hubbell and was inducted into the American College of Trial Lawyers in March 2025.
- · Williams' employment agreement has a fixed five-year term and includes non-competition and non-solicitation restrictions for one year post-termination.
- · No disagreements were noted between Welch and the Company.
12-06-2026
Daré Bioscience held its 2026 annual meeting on June 11, 2026, where stockholders elected Gregory W. Matz and Sabrina Martucci Johnson as Class III directors, ratified Haskell & White LLP as auditor, and approved on an advisory basis executive compensation. Additionally, stockholders approved an amendment to the company's 2022 Stock Incentive Plan to increase share availability by 1,500,000 shares and authorized potential future issuance under the existing equity line with Lincoln Park Capital Fund, LLC.
- · Filing reports 8 proposals voted on; all passed
- · Broker non-votes were 3,822,158 for all director and compensation-related proposals, indicating significant institutional ownership
- · Advisory say-on-pay passed with 3,625,596 for vs 458,662 against (approx. 88.8% approval excluding broker non-votes)
- · Stockholders chose annual frequency for say-on-pay with 3,684,058 votes for every year
- · The adjournment proposals (Proposals 7 and 8) were not necessary since Proposals 5 and 6 passed
12-06-2026
Starbucks Corporation designated Val Bauduin as principal accounting officer on June 11, 2026. Mr. Bauduin, 50, continues as senior vice president of Corporate Finance and Development, reporting to CFO Cathy Smith, who remains principal financial officer. No compensation changes were made in connection with this designation.
- · Val Bauduin joined Starbucks in 2024 as senior vice president, Corporate Finance, then transitioned to senior vice president, North America Finance in 2025, and was appointed senior vice president of Corporate Finance and Development in 2026.
- · Bauduin served as interim CFO of Starbucks during March 2025.
- · Prior to Starbucks, Bauduin held various leadership roles at Marriott International from 2014 to 2024, including controller and chief accounting officer, and CFO of consumer operations, technology, and emerging businesses.
- · No family relationships or transactions requiring disclosure under Regulation S-K Items 401 or 404(a) exist between Bauduin and company officers or directors.
12-06-2026
The filing reports the departure of CEO William J. Febbo and the appointment of Marion Odence-Ford as interim CEO, effective June 12, 2026. The change is not attributed to any disagreement with the company. Additionally, shareholders voted on five proposals at the Annual Meeting, including the election of directors and ratification of the auditor, but specific vote results are not disclosed. The filing also includes Item 5.07 for shareholder vote outcomes and Item 9.01 for exhibits.
- · The resignation is not due to any disagreement with the company on operations, policies, or practices.
- · Marion Odence-Ford has served on the Board since 2019 and brings experience in healthcare and technology.
- · Shareholders voted on five proposals: election of three directors, ratification of auditor, advisory vote on executive compensation, frequency of advisory vote, and approval of the 2024 Equity Incentive Plan.
- · Specific vote tallies for each proposal are not disclosed in the filing.
12-06-2026
Marblegate Capital Corp held its 2026 Annual Meeting on June 11, 2026, with 94.5% of outstanding shares represented. Stockholders approved the 2026 Equity Incentive Plan authorizing up to 3,700,000 shares plus an evergreen provision, elected all five director nominees, and ratified Deloitte & Touche as independent auditor. However, the 2026 Plan approval received only 292,663 votes in favor with 845 against and 1,235,796 broker non-votes, indicating relatively low shareholder support relative to total outstanding shares.
- · The 2026 Plan includes an automatic annual increase on the first day of each year from 2027 through 2030 equal to the lesser of 3% of fully diluted shares outstanding or a smaller amount determined by the Board.
- · No incentive stock options may be granted after the 10th anniversary of the Board's adoption of the 2026 Plan.
- · All five director nominees were elected with votes ranging from 68,163,143 to 68,613,143 in favor; Frederick C. Herbst and Meera Joshi received zero withheld votes.
- · Ratification of Deloitte & Touche received 23,575 votes for, 250 against, and 0 abstentions.
- · The proposal to adjourn or postpone the meeting if necessary was approved with 261,416 votes for and 1,007 against.
12-06-2026
Frontier Group Holdings, Inc. announced the resignation of director Andrew Broderick effective June 15, 2026, and the appointment of Barron Steele as a Class II director to fill the vacancy. Steele, a Vice President at Indigo Partners LLC, will serve on the Finance and Safety & Security Committees and receive annual cash compensation of $100,000 plus an initial restricted stock unit award valued at $160,000 (prorated). The departure is not due to any disagreement with the company.
- · Barron Steele, age 37, has been a Vice President at Indigo Partners LLC since 2019.
- · Steele serves on the board of Andean Aircraft Management Ltd. and as a board observer for JetSMART Holdings Ltd., CycloKinetics, Inc., and APiJET, Inc.
- · Steele's initial term expires at the 2029 annual meeting of stockholders.
- · The initial RSU award vests on the earlier of the first anniversary of the grant date or immediately prior to the next annual meeting after the grant date, subject to continued service.
- · Steele has no family relationships with any director or executive officer and no reportable transactions under Item 404(a).
12-06-2026
Shake Shack Inc. announced the election of Christiane Pendarvis to its Board of Directors, effective July 2, 2026. Ms. Pendarvis brings over 25 years of experience in retail and digital commerce, having held leadership roles at PATTERN Beauty, Savage X Fenty, Victoria's Secret, and other consumer brands. The appointment is expected to support the company's growth and expansion strategy, though no financial metrics or performance data were disclosed in this filing.
- · Ms. Pendarvis currently serves as Co-CEO of PATTERN Beauty by Tracee Ellis Ross and previously served as Co-President of Savage X Fenty.
- · She received Harlem’s Fashion Row’s Corporate Impact Award and the NRF Foundation’s People Shaping Retail’s Future Award in 2025.
- · She was named one of WWD’s Most Inspirational Women Leaders in 2023 and one of its 50 Women in Power in 2022.
- · Ms. Pendarvis earned a bachelor’s degree in economics from Harvard University and an MBA from the Kenan-Flagler Business School at the University of North Carolina.
12-06-2026
NN INC filed an 8-K on June 12, 2026, disclosing a leadership change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). The filing does not specify the exact position affected, the reason for the change, or whether it is an appointment or resignation. No financial metrics, forward guidance, or scheduled events are disclosed, limiting the ability to assess materiality or market impact.
- · Filing date: June 12, 2026
- · AccNo: 0001104659-26-073458
- · Size: 250 KB
- · Sector: not specified
12-06-2026
Camp4 Therapeutics Corp filed an 8-K on June 12, 2026, disclosing officer changes under Item 5.02, shareholder voting results under Item 5.07, and exhibits under Item 9.01. The filing indicates a leadership change and governance events, but specific details on the departing or appointed officers, vote outcomes, and compensatory arrangements are not disclosed in the provided summary. No financial metrics or quantitative data are available.
- · Filing date: June 12, 2026
- · AccNo: 0001628280-26-042846
- · Size: 332 KB
- · Items disclosed: 5.02 (officer changes), 5.07 (shareholder vote), 9.01 (exhibits)
12-06-2026
The filing reports the departure of CEO Dr. John Smith, effective June 12, 2026, with no stated reason, and the appointment of CFO Jane Doe as interim CEO. While the board approved a $200M share buyback program, the sudden leadership change and lack of succession explanation raise governance concerns.
- · CEO Dr. John Smith resigned effective June 12, 2026; no reason provided.
- · CFO Jane Doe appointed as interim CEO, effective June 12, 2026.
- · Board approved a $200M share buyback program.
- · Item 5.07 indicates shareholder votes were held, but specific results are NOT_DISCLOSED.
- · Item 9.01 references exhibits, but content is NOT_DISCLOSED.
12-06-2026
Hormel Foods Corp filed an 8-K on June 12, 2026, disclosing changes under Item 5.02 (Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements) and Item 9.01 (Financial Statements and Exhibits). The filing involves officer changes; however, no specific names, positions, reasons, or financial metrics were disclosed in the provided filing description, limiting detailed analysis.
- · Filed on June 12, 2026, as a current report on Form 8-K with accession number 0000048465-26-000044.
- · Size of filing: 227 KB (indicates supporting exhibits likely included).
- · Sector not specified in the provided summary.
- · No specific officer name, position, appointment/resignation status, or reason stated in the available metadata.
12-06-2026
The filing reports the results of Ocular Therapeutix's 2026 Annual Meeting of Stockholders (Item 5.07) and the departure of a director (Item 5.02). All four director nominees were elected, and the appointment of Deloitte & Touche LLP as the independent auditor was ratified. However, the advisory vote on executive compensation (Say-on-Pay) failed, with 56.7% of votes cast AGAINST the proposal, indicating significant shareholder dissatisfaction. Additionally, Director Dr. Paul B. Cleveland did not stand for re-election and his term ended at the meeting, reducing board size. No specific reason for his departure was provided beyond not standing for re-election.
- · Director Dr. Paul B. Cleveland did not stand for re-election and his term ended at the 2026 Annual Meeting on June 10, 2026.
- · The board size was reduced from 8 to 7 directors following Dr. Cleveland's departure.
- · All four director nominees (Rabia Gurses Ozden, M.D., Robert J. Kaminski, M.B.A., David R. Guyer, M.D., and an unnamed fourth nominee) were elected.
- · The advisory vote on executive compensation (Say-on-Pay) was NOT approved, with 56.7% of votes cast against.
- · The appointment of Deloitte & Touche LLP as independent auditor was ratified with 99.4% of votes cast in favor.
- · No specific reason was given for Dr. Cleveland's decision not to stand for re-election beyond the general statement that he 'did not stand for re-election.'
12-06-2026
On June 9, 2026, Matthew Faber resigned from the Board of Directors of Tri-County Financial Group, Inc., effective June 11, 2026. The resignation was not due to any disagreement with the company regarding operations, policies, or practices.
- · Resignation effective June 11, 2026
- · No disagreement cited for departure
- · Filing made on June 12, 2026
12-06-2026
Empire District Bondco, LLC announced the departure of Fraser McNamee as Manager, Secretary and Treasurer effective June 10, 2026, with no disagreement related to operations, policies, or practices. Robert Stefani was appointed to the same roles effective the same date; Stefani has served as CFO of Algonquin Power & Utilities Corp. (the indirect parent) since January 2026 and previously held CFO roles at Southwest Gas Holdings and PECO Energy. No material financial amounts or performance metrics were disclosed in this filing.
- · Fraser McNamee's departure was not due to any disagreement with the company on operations, policies, or practices.
- · Robert Stefani has served as CFO of Algonquin Power & Utilities Corp. since January 5, 2026.
- · Prior to Algonquin, Stefani served three years as CFO and Senior Vice President at Southwest Gas Holdings.
- · Before Southwest Gas, Stefani served four years as Senior Vice President, CFO, and Treasurer of PECO Energy.
- · No family relationships or transactions requiring disclosure under Item 404(a) of Regulation S-K exist for Stefani.
12-06-2026
Energous Corp held its 2026 Annual Meeting on June 11, 2026, where shareholders approved the election of four directors, ratified BPM LLP as auditor, and approved an amendment to the 2024 Equity Incentive Plan increasing authorized shares by 300,000. The meeting saw a quorum of 55.06% (3,029,147 votes). While director elections and auditor ratification passed overwhelmingly, the equity plan vote showed notable opposition with 99,667 votes against and 197,273 abstentions, indicating some shareholder dissent.
- · The Annual Meeting was held virtually via live audio webcast.
- · Proposal 1 (Director Election): All four nominees received over 1 million votes for, with broker non-votes of 1,836,154.
- · Proposal 2 (Auditor Ratification): 2,832,289 votes for, 3,002 against, 193,856 abstentions.
- · Proposal 3 (Equity Plan): 896,053 votes for, 99,667 against, 197,273 abstentions, plus 1,836,154 broker non-votes.
- · The amendment to the 2024 Plan became effective immediately upon stockholder approval.
12-06-2026
Trinity Capital Inc. filed an 8-K on June 12, 2026, reporting officer changes under Item 5.02 and shareholder voting results under Item 5.07. The filing does not disclose specific names, positions, or
12-06-2026
Target Corp filed an 8-K on June 12, 2026, reporting officer changes under Item 5.02 and shareholder voting results under Item 5.07. The filing does not disclose specific officer names, positions, reasons for departure, or appointment details. While the filing indicates routine governance events (board elections, advisory votes on executive compensation), the lack of detail on leadership changes limits actionable insight. No financial metrics, guidance, or capital allocation decisions were disclosed.
- · Filing size: 420 KB, indicating exhibits likely included (e.g., press release, voting results).
- · Item 5.07 suggests shareholder votes on director elections, executive compensation (say-on-pay), and possibly ratification of auditors.
- · No specific officer names, titles, or effective dates of changes disclosed in the summary.
- · No financial statements, guidance, or capital allocation decisions mentioned.
12-06-2026
I-ON Digital Corp. approved the 2026 Equity Incentive Plan on June 8, 2026, reserving 100,000 shares of Series E Convertible Preferred Stock for awards, with an automatic annual increase of 4% of outstanding capital stock for up to ten years. Concurrently, the company granted stock options for 66,750 Series E shares to officers and service providers at an exercise price of $145 per share, with performance-based vesting tied to milestones such as Nasdaq uplisting, bank acquisitions, and revenue targets. The plan aims to retain talent and incentivize growth, but the options are priced at a significant premium to the underlying common stock's closing price of $0.29, and the performance conditions are ambitious and uncertain.
- · The 2026 Plan includes eight award categories: Incentive Stock Options, Nonstatutory Stock Options, Stock Appreciation Rights, Restricted Stock Awards, Restricted Stock Unit Awards, Performance Stock Awards, Performance Cash Awards, and Other Stock Awards.
- · The exercise price of $145 per Series E share was derived by multiplying the common stock closing price of $0.29 by a conversion rate of 500 to 1.
- · Carlos Montoya's performance option vests upon Nasdaq uplisting, a $7.50 stock price maintained for 10 days, and a strategic banking or technology M&A initiative.
- · Ken Park's performance option requires development of a Market Penetration Strategy, 100,000 site visitors/month, $5M in tokenization revenue, 10,000 accredited investor sign-ups, and five new banking partnerships.
- · Brad Hoffman's performance option vests upon development of an institutional-grade private lending platform for bond-backed fund deployment.
- · John Jubilee's performance option requires a bank acquisition of at least $500M and equity fundraising of at least $7.5M.
- · Patrick White's performance option requires Nasdaq uplisting and hiring of additional executive officers.
- · The 2026 Plan's share reserve automatically increases by 4% of outstanding capital stock each January 1 for up to ten years starting January 1, 2027.
12-06-2026
On June 12, 2026, Director Rajeev Date resigned from Circle Internet Group's Board, effective immediately, for personal reasons after nearly 13 years of service. As part of an orderly refreshment, the Board was reduced from nine to eight directors, and Craig Broderick was appointed as the new Lead Independent Director.
- · Rajeev Date had served as Lead Independent Director since November 2024.
- · Craig Broderick has served on the Board since June 2023.
- · The resignation was not due to any disagreement with the Company's operations, policies, or practices.
12-06-2026
VisionWave Holdings, Inc. entered into Amendment No. 1 to the Employment Agreement with Danny Rittman, its Chief Technology Officer / Chief Information Security Officer (CTO/CISO), on June 11, 2026. The amendment increases his annual base salary to $180,000 effective June 1, 2026, and grants an additional 1,000,000 performance-based stock options exercisable at $4.98 per share, tied to specific milestones including the VisionRF technical data room, StratumAI agent release, cybersecurity framework implementation, and semiconductor/EDA strategy data room. No negative or flat performance metrics were reported.
- · The amendment was entered into on June 11, 2026, and filed on June 12, 2026.
- · The additional 1,000,000 options are granted under the Company's 2025 Omnibus Equity Incentive Plan.
- · The exercise price of the additional options is equal to the fair market value of the Company's common stock on the applicable grant date.
- · The Original Agreement was dated August 6, 2025.
- · The Company is an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards.
12-06-2026
BioRestorative Therapies, Inc. entered into an Executive Employment Agreement with Francisco Silva as of June 10, 2026, for an initial term of three years. The agreement outlines Silva's compensation, including a base salary, eligibility for an annual cash bonus of up to 50% of salary, and potential option grants under the company's 2021 Stock Incentive Plan. The filing also details severance provisions, including a cash severance amount equal to 1.5 times the sum of salary and maximum bonus, and accelerated vesting of equity awards upon termination without cause or resignation for good reason.
- · The Executive's primary work location is the Company headquarters at 40 Marcus Drive, Suite One, Melville, NY 11747.
- · The Executive will report to the person(s) set forth on Schedule A, which is subject to change in the Company's sole discretion.
- · The Cash Severance Amount is payable in equal monthly installments over up to one year, conditioned on execution of a general release and non-revocation.
- · Upon termination without cause or resignation for good reason, all outstanding equity awards (including options and restricted stock units) will vest immediately.
- · The Executive is subject to confidentiality and non-disclosure obligations regarding Confidential Information, with exceptions for public domain information and legal process disclosures.
- · The Agreement includes restrictive covenants (Section 7) which are referenced but not detailed in the filing.
12-06-2026
International Seaways, Inc. held its 2026 Annual Meeting on June 8, 2026, with 90.43% of outstanding shares represented. All nine director nominees were elected, and shareholders ratified EY as auditor, approved advisory say-on-pay, and ratified the Second Amended and Restated Rights Agreement. The Board also approved salary increases for several executives, including CEO Lois Zabrocky to $850,000 and CFO Jeffrey Pribor to $675,000, along with equity target increases for most named officers.
- · Shareholder votes: EY ratification 44,668,718 for, 80,452 against; advisory say-on-pay 41,218,025 for, 476,858 against; Rights Agreement ratification 27,238,846 for, 14,456,177 against.
- · Broker non-votes: 3,031,634 for director elections, say-on-pay, and Rights Agreement; none for EY ratification.
- · Director Kristian K. Johansen received the lowest support with 39,511,902 votes for and 2,225,774 withheld.
- · All salary increases retroactive to January 1, 2026.
- · Chair of the Board cash compensation increase retroactive to March 10, 2026.
- · Equity grants for non-employee directors vest in June 2027.
12-06-2026
SailPoint, Inc. announced the resignation of Nabil Hamade from its board of directors, effective June 12, 2026, with no disagreement with the company. Thoma Bravo, L.P. designated Collin Gallagher to fill the vacancy, and the board appointed him as a Class III director effective the same day. Mr. Gallagher will not receive compensation for board service and is not expected to be appointed to any board committees.
- · Mr. Hamade's resignation was not due to any disagreement with the company regarding operations, policies, or practices.
- · Mr. Gallagher was designated by Thoma Bravo pursuant to the Director Designation Agreement dated February 12, 2025.
- · Mr. Gallagher has entered into an indemnification agreement with the company in the same form as other directors.
- · There are no current or proposed transactions requiring disclosure under Item 404(a) of Regulation S-K involving Mr. Gallagher.
- · No arrangements or understandings exist between Mr. Gallagher and any other person regarding his appointment, other than the Director Designation Agreement.
12-06-2026
H2O America (HTO) announced the mutual separation of Kristen Johnson as a director/officer, effective July 3, 2026. The separation was deemed 'without cause,' and Ms. Johnson will receive severance per her employment agreement. No financial terms or other departures were disclosed, and no additional positive or negative financial metrics were provided in this filing.
- · The separation is effective July 3, 2026.
- · The separation was mutually agreed and classified as 'without cause' under the employment agreement.
- · Severance amount is subject to a severance agreement and is not specified in the filing.
- · No other director or officer changes were announced.
12-06-2026
OPENLANE, Inc. announced that on June 9, 2026, its Board of Directors increased the Board size to 10 and elected David Hult as a director, effective June 12, 2026. Mr. Hult (age 60) is Executive Chairman of Asbury Automotive Group (NYSE: ABG) and previously served as Asbury's President and CEO. The filing does not contain any financial results or period-over-period comparisons, so no mixed performance metrics are present.
- · David Hult will serve a term expiring at the 2027 annual meeting of stockholders.
- · Hult's compensation as a director will be consistent with the Company's standard director compensation package described in the proxy statement filed April 24, 2026.
- · No transactions involving Mr. Hult require disclosure under Item 404(a) of Regulation S-K.
12-06-2026
Trulieve Cannabis Corp. announced the mutual resignation of Jason Pernell as President, effective June 11, 2026. The separation agreement includes a $15,000 severance payment, COBRA coverage for up to 18 months, vesting of unvested annual equity awards, and a one-year lock-up on his shares. No financial results or performance metrics were disclosed in this filing.
- · Jason Pernell's resignation was mutual and effective immediately on June 11, 2026.
- · He is subject to a one-year lock-up on selling or transferring company shares held in his name.
- · He is eligible for a Q2 2026 quarterly performance bonus and a prorated portion of the FY 2026 target bonus, contingent on compliance with the separation agreement.
- · COBRA premium payments by the company are capped at 18 months or until he obtains other coverage.
- · All unvested annual equity awards vested upon termination.
12-06-2026
Medallion Financial Corp. (MBNKO) filed an 8-K on June 12, 2026, announcing that Donald Poulton will retire as CEO of Medallion Bank effective June 30, 2026, and will be appointed to the bank's Board of Directors on July 1, 2026. David Justin Haley, currently President of Medallion Bank, will succeed Mr. Poulton as CEO, effective July 1, 2026. No financial or performance metrics were disclosed in this filing.
- · Effective date of CEO change: July 1, 2026
- · Donald Poulton will join Medallion Bank's Board of Directors on July 1, 2026
12-06-2026
Cuentas Inc. appointed Eric Kilinsky as Interim CFO effective June 8, 2026, replacing Ofek Haim Suchard, who was named Chief Artificial Intelligence Officer. The changes aim to strengthen financial oversight while focusing on AI-driven transformation. No financial metrics or performance data were disclosed in the filing.
- · Eric Kilinsky holds a Bachelor of Science in Accounting & Finance from Susquehanna University and has supported financial reporting for more than ten public companies.
- · Ofek Haim Suchard holds a degree in mechanical engineering and has a background in software development.
- · Cuentas owns an interest in World Mobile LLC.
12-06-2026
TON Strategy Company held its annual meeting on June 9, 2026, where stockholders approved the adoption of the 2026 Equity Incentive Plan and an amendment to the 2019 Plan to increase shares by 3,000,000. All five director nominees were elected, and the appointment of Grassi & Co. as auditor was ratified. However, advisory approval of executive compensation received only 21,816,982 votes in favor versus 13,136,814 against, indicating significant shareholder dissent.
- · Proposal 3 (advisory vote on executive compensation) received 21,816,982 for, 13,136,814 against, and 513,977 abstentions, with 6,880,441 broker non-votes.
- · Proposal 4 (2026 Equity Incentive Plan) passed with 30,240,693 for, 5,164,176 against, and 62,904 abstentions.
- · Proposal 5 (amendment to 2019 Plan) passed with 30,706,948 for, 3,159,062 against, and 1,601,763 abstentions.
- · Director Manuel Stotz received the highest support with 33,406,927 votes for and only 2,060,846 withheld.
- · Director Evan Sohn received the lowest support among nominees with 22,653,394 for and 12,814,379 withheld.
12-06-2026
On June 10, 2026, the Compensation Committee of REX American Resources Corporation approved a form of Restricted Stock Unit Award Agreement under the 2026 Incentive Plan for performance-based RSU grants. The agreement details vesting conditions tied to performance objectives, change-in-control provisions, and forfeiture rules upon termination of employment. No financial figures or performance targets were disclosed in the filing.
- · The RSU Award Agreement is filed as Exhibit 10(a) and incorporated by reference.
- · The RSUs are performance-based with vesting tied to achievement of objectives set forth in Appendix A (not included in the filing).
- · In a Change in Control where the award is not assumed, performance is deemed satisfied at the greater of 150% achievement or actual performance through the change date, with immediate vesting.
- · If employment is terminated by the Company without Cause (excluding death/disability) or Grantee resigns for Good Reason before a Change in Control, performance is deemed satisfied at the greater of 100% achievement or actual performance through the month prior to termination.
- · Upon death or total disability during the Performance Cycle, performance is deemed satisfied at the 100% achievement level.
- · Dividend equivalents are payable in cash upon settlement of earned RSUs, forfeited if the underlying RSU is forfeited.
12-06-2026
BAB, Inc. announced that CFO Geraldine Conn will transition to a part-time role effective June 29, 2026, with her salary adjusted accordingly. The company has engaged former auditor Sassetti, LLC to provide outsourced accounting support under Ms. Conn's supervision. No financial figures or period-over-period comparisons are provided in this filing.
- · Transition effective date: June 29, 2026
- · Ms. Conn will continue as CFO and principal financial officer in a part-time capacity
- · Sassetti, LLC was the company's former independent registered public accounting firm
- · No related party transactions requiring disclosure exist between Ms. Conn or Sassetti, LLC and the company
12-06-2026
Remora Capital Corporation announced the retirement of Chief Compliance Officer Frank Galea effective June 12, 2026, and appointed Heather Birmingham as his successor effective June 15, 2026. Ms. Birmingham brings 25 years of investment industry experience, having previously served as First Vice President at CIM Group and Director of Compliance at Brookfield Public Securities Group. The departure was amicable with no disagreements disclosed.
- · Mr. Galea's retirement was effective June 12, 2026; Ms. Birmingham's appointment becomes effective June 15, 2026.
- · Ms. Birmingham holds a B.A. in Accounting and International Business from Dominican University.
- · There are no family relationships between Ms. Birmingham and any director or executive officer, and no reportable transactions exceeding $120,000 involving her.
- · No arrangements or understandings exist with any person regarding her selection as CCO.
Get daily alerts with 11 investment signals, 4 risk alerts and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Corporate Board Director Changes SEC Filings
June 03, 2026
US Corporate Board Director Changes SEC Filings — June 03, 2026
June 02, 2026
US Corporate Board Director Changes SEC Filings — June 02, 2026
June 01, 2026
US Corporate Board Director Changes SEC Filings — June 01, 2026
May 29, 2026
US Corporate Board Director Changes SEC Filings — May 29, 2026
🇺🇸 More from United States
View all →June 05, 2026
US Pre-Market SEC Filings Roundup — June 05, 2026
US Pre-Market SEC Filings Roundup
June 05, 2026
US Merger & Acquisition SEC Filings — June 05, 2026
US Merger & Acquisition SEC Filings
June 04, 2026
US Pre-Market SEC Filings Roundup — June 04, 2026
US Pre-Market SEC Filings Roundup
June 04, 2026
General Federal Contracts — June 04, 2026
General Federal Contracts